Physician profile
Ruth T Lim
NPI 1871587998
$4,980.22
in general payments reported to CMS, 2019-2025
31 companies · $1,755 in 2025
The $1,755 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $145 · 2021: $726 · 2022: $504 · 2023: $335 · 2024: $802 · 2025: $1,755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,892.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $704.48 | 2019-2025 | Wegovy |
| Teva Pharmaceuticals USA, INC. | $483.86 | 2021-2022 | |
| Medtronic, INC. | $348.67 | 2024-2025 | Intellis Adaptivestim, Interstim, Venaseal |
| Amgen INC. | $265.06 | 2025 | Otezla |
| Glaxosmithkline, LLC. | $262.66 | 2019 | |
| Stemline Therapeutics INC. | $248.55 | 2023-2025 | Orserdu |
| Eisai INC. | $238.60 | 2024-2025 | |
| Intra-Sana Laboratories | $165.01 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Tempus Ai, INC | $161.40 | 2024 | Xt Cdx |
| Edwards Lifesciences Corporation | $160.81 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Romark Laboratories, Lc | $145.10 | 2020 | |
| Biosense Webster, INC. | $144.65 | 2025 | Carto 3 |
| Davol INC. | $136.49 | 2021 | |
| Madrigal Pharmaceuticals | $125.51 | 2025 | Rezdiffra |
| Menarini Silicon Biosystems, INC. | $124.61 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $121.84 | 2025 | Ogsiveo |
| Genzyme Corporation | $121.84 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $121.37 | 2019 | |
| Inspire Medical Systems, INC. | $117.53 | 2023 | Inspire |
| Boston Scientific Corporation | $111.49 | 2019 | |
| Kyowa Kirin, INC. | $108.60 | 2021 | |
| Acadia Pharmaceuticals INC | $107.28 | 2021 | |
| Phathom Pharmaceuticals, INC. | $107.17 | 2024 | Voquezna |
| Rare Disease Therapeutics, INC. | $96.84 | 2019 | |
| Asahi Intecc USA, INC. | $92.08 | 2025 | Asahi Interventional Radiology Wires |
| Pfizer INC. | $40.79 | 2025 | |
| Penumbra, INC. | $33.76 | 2025 | Indigo System |
| Photonicare INC | $25.51 | 2025 | Otosight Middle Ear Scope |
| Merck Sharp & Dohme LLC | $24.34 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.14 | 2019 | |
| Cranial Technologies, INC | $14.18 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruth Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.